Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus

Computational Biology and Chemistry

Volumn 35, Issue 5, 2011, Pages 293-297

  Gu, Jiangyong ^a   Zhang, Hu ^a,b   Chen, Lirong ^a   Xu, Shun ^b   Yuan, Gu ^a   Xu, Xiaojie ^a  

^a PEKING UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Drug target network; Network analysis; Polypharmacology; Traditional Chinese Medicine; Type II diabetes; Virtual screening

Indexed keywords

DRUG-TARGET NETWORK; POLYPHARMACOLOGY; TRADITIONAL CHINESE MEDICINE; TYPE II; VIRTUAL SCREENING;

ELECTRIC NETWORK ANALYSIS;

MEDICINE;

ANTIDIABETIC AGENT; HERBACEOUS AGENT; LIGAND;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOLOGICAL MODEL; CHINESE MEDICINE; FACTUAL DATABASE; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DRUGS, CHINESE HERBAL; HUMANS; HYPOGLYCEMIC AGENTS; LIGANDS; MEDICINE, CHINESE TRADITIONAL; MODELS, BIOLOGICAL; NEURAL NETWORKS (COMPUTER); PRINCIPAL COMPONENT ANALYSIS; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80052088034     PISSN: 14769271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiolchem.2011.07.003     Document Type: Article

References (34)

1. A.L. Barabasi Scale-free networks: a decade and beyond Science 325 2009 412 413
2. A.L. Barabasi, and Z.N. Oltvai Network biology: understanding the cell's functional organization Nat. Rev. Genet. 5 2004 101 115
3. S.I. Berger, and R. Iyengar Network analyses in systems pharmacology Bioinformatics 25 2009 2466 2472
4. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne The protein data bank Nucleic Acids Res. 28 2000 235 242 (Pubitemid 30047768)
5. M.D. Camberos, and J.C. Cresto Insulin-degrading enzyme hydrolyzes ATP Exp. Biol. Med. 232 2007 281 292 (Pubitemid 46203297)
6. G. Csardi, and T. Nepusz The igraph software package for complex network research InterJournal Complex Systems 2006 1695 1703
7. C. DeSouza, and V. Fonseca Therapeutic targets to reduce cardiovascular disease in type 2 diabetes Nat. Rev. Drug Discov. 8 2009 361 367
8. T.N. Doman, S.L. McGovern, B.J. Witherbee, T.P. Kasten, R. Kurumbail, W.C. Stallings, D.T. Connolly, and B.K. Shoichet Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B J. Med. Chem. 45 2002 2213 2221 (Pubitemid 34525801)
9. M. Girvan, and M.E.J. Newman Community structure in social and biological networks Proc. Natl. Acad. Sci. U.S.A. 99 2002 7821 7826 (Pubitemid 34650963)
10. K.I. Goh, M.E. Cusick, D. Valle, B. Childs, M. Vidal, and A.L. Barabasi The human disease network Proc. Natl. Acad. Sci. U.S.A. 104 2007 8685 8690 (Pubitemid 47175372)
11. J. Goni, F.J. Esteban, N.V. de Mendizabal, J. Sepulcre, S. Ardanza-Trevijano, I. Agirrezabal, and P. Villoslada A computational analysis of protein-protein interaction networks in neurodegenerative diseases BMC Syst. Biol. 2 2008 52
12. J.Y. Gu, G. Yuan, Y.H. Zhu, and X.J. Xu Computational pharmacological studies on cardiovascular disease by Qishen Yiqi Diwan Sci. China Ser. B 52 2009 1871 1878
13. S.C. Janga, and B. Contreras-Moreira Dissecting the expression patterns of transcription factors across conditions using an integrated network-based approach Nucleic Acids Res. 38 2010 6841 6856
14. S.C. Janga, and A. Tzakos Structure and organization of drug-target networks: insights from genomic approaches for drug discovery Mol. Biosyst. 5 2009 1536 1548
15. H. Jeong, S.P. Mason, A.L. Barabasi, and Z.N. Oltvai Lethality and centrality in protein networks Nature 411 2001 41 42 (Pubitemid 32428180)
16. G. Jones, P. Willett, R.C. Glen, A.R. Leach, and R. Taylor Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 267 1997 727 748 (Pubitemid 27170693)
17. B.H. Junker, D. Koschutzki, and F. Schreiber Exploration of biological network centralities with CentiBiN BMC Bioinformatics 7 2006 219
18. M. Kanehisa, S. Goto, M. Furumichi, M. Tanabe, and M. Hirakawa KEGG for representation and analysis of molecular networks involving diseases and drugs Nucleic Acids Res. 38 2010 D355 D360
19. H. Kitano Biological robustness Nat. Rev. Genet. 5 2004 826 837 (Pubitemid 39457498)
20. E. Klipp, R.C. Wade, and U. Kummer Biochemical network-based drug-target prediction Curr. Opin. Biotechnol. 21 2010 511 516
21. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25 (Pubitemid 27046991)
22. C. Luni, J. Shoemaker, K. Sanft, L. Petzold, and F. Doyle Confidence from uncertainty - a multi-target drug screening method from robust control theory BMC Syst. Biol. 4 2010 161
23. L.G. Mellbin, M. Anselmino, and L. Ryden Diabetes, prediabetes and cardiovascular risk Eur. J. Cardiovas. Prev. Rehabil. 17 2010 S9 S14
24. N. Morral Novel targets and therapeutic strategies for type 2 diabetes Trends Endocrinol. Metab. 14 2003 169 175 (Pubitemid 36733902)
25. D. Plewczynski, M. Lazniewski, R. Augustyniak, and K. Ginalski Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database J. Comput. Chem. 32 2011 742 755
26. X.B. Qiao, T.J. Hou, W. Zhang, S.L. Guo, and S.J. Xu A 3D structure database of components from Chinese traditional medicinal herbs J. Chem. Inform. Comput. Sci. 42 2002 481 489 (Pubitemid 35355253)
27. S. Runge, H. Thogersen, K. Madsen, J. Lau, and R. Rudolph Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain J. Biol. Chem. 283 2008 11340 11347
28. M.E. Smoot, K. Ono, J. Ruscheinski, P.L. Wang, and T. Ideker Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 2011 431 432
29. M. Stumvoll, B.J. Goldstein, and T.W. van Haeften Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 2005 1333 1346
30. Tong, X.L.; Zhu, Y.H.; Zhou, S.P.; 2009. A pharmaceutical composition for treating diabetes, China patent, CN101357174.
31. I. Vogt, and J. Mestres Drug-target networks Mol. Inform. 29 2010 10 14
32. D.S. Wishart, C. Knox, A.C. Guo, D. Cheng, S. Shrivastava, D. Tzur, B. Gautam, and M. Hassanali DrugBank: a knowledgebase for drugs, drug actions and drug targets Nucleic Acids Res. 36 2008 D901 D906
33. M.A. Yildirim, K.I. Goh, M.E. Cusick, A.L. Barabasi, and M. Vidal Drug-target network Nat. Biotechnol. 25 2007 1119 1126 (Pubitemid 47538114)
34. M. Zhu, L. Gao, X. Li, Z.C. Liu, C. Xu, Y.Q. Yan, E. Walker, W. Jiang, B. Su, X.J. Chen, and H. Lin The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network J. Drug Target. 17 2009 524 532